Snowdrop Science uses a next-generation frontend for molecular and orbital visualisation, combined with an AI backend, for accelerated drug discovery. We are building a platform that utilises its backend to suggest changes to organometallic anticancer complexes to improve the selectivity and reduce the toxicity of these compounds, which are made visible through the custom-built frontend.
| Employees | 1 (1 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular Snowdrop Science employee's phone or email?
Jed Walsh is the Founder and CEO of Snowdrop Science.
1 people are employed at Snowdrop Science.
Snowdrop Science is based in London, England.